Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

Cephalon (MM) (CEPH)

81,49

0,00

(0,00%)

Fermé 21 Juin 10:00PM

0,00

0,00

(0,00%)

Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman

Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman PR Newswire OXFORD, England, June 26, 2013 OXFORD, England, June 26, 2013...

- (25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...

Teva Completes Acquisition of Cephalon

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has completed its acquisition of Cephalon, Inc...

Teva and Cephalon Receive European Commission Approval For Acquisition

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Cephalon Inc. (NASDAQ: CEPH) announced today that they received approval...

S&P Indices Announces Change to U.S. Index

S&P Indices Announces Change to U.S. Index PR Newswire NEW YORK, Oct. 11, 2011 NEW YORK, Oct. 11, 2011 /PRNewswire/ -- TE Connectivity Ltd...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

- Amended Statement of Ownership (SC 13G/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No...

Zacks Sell List Highlights: Molex, CenturyLink, Blue Nile and Cephalon

Zacks Sell List Highlights: Molex, CenturyLink, Blue Nile and Cephalon PR Newswire CHICAGO, Sept. 7, 2011 CHICAGO, Sept. 7, 2011 /PRNewswire/...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 201...

Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

Cephalon Reported Financial Results for the Second Quarter of 2011

Cephalon Reported Financial Results for the Second Quarter of 2011 Sales For The Period Were $730 Million Basic Income Per Common Share Increased...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

First Inter Mer

Terra Nova Resources

Cosmo Energy (PK)

Liberty Prime Series 202...

Bond 5.5% until Jan 15 2...

Energy Transfer

Global X ETF ICAV

iShares MSCI EMU Screene...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.